177 related articles for article (PubMed ID: 6136487)
1. Rebound phenomena: results of a 10 years' (1970--1980) literature review.
Lupolover R; Dazzi H; Ward J
Int Pharmacopsychiatry; 1982; 17(4):194-237. PubMed ID: 6136487
[TBL] [Abstract][Full Text] [Related]
2. Rebound insomnia and rebound anxiety: a review.
Kales A; Soldatos CR; Bixler EO; Kales JD
Pharmacology; 1983; 26(3):121-37. PubMed ID: 6132413
[TBL] [Abstract][Full Text] [Related]
3. Drugs for psychiatric disorders.
Med Lett Drugs Ther; 1994 Oct; 36(933):89-96. PubMed ID: 7935156
[No Abstract] [Full Text] [Related]
4. Rebound insomnia: a critical review.
Gillin JC; Spinweber CL; Johnson LC
J Clin Psychopharmacol; 1989 Jun; 9(3):161-72. PubMed ID: 2567741
[TBL] [Abstract][Full Text] [Related]
5. Anxiolytics and sedative/hypnotics dependence.
Busto UE; Sellers EM
Br J Addict; 1991 Dec; 86(12):1647-52. PubMed ID: 1686199
[TBL] [Abstract][Full Text] [Related]
6. [Unwanted effects of psychotropic drugs--selected results from a 10-year multicenter project monitoring drugs in psychiatry].
Grohmann R; Schmidt LG; Antretter K; Rüther E
Internist (Berl); 1990 Jul; 31(7):468-74. PubMed ID: 1975570
[No Abstract] [Full Text] [Related]
7. Insomnia in generalized anxiety disorder: polysomnographic, psychometric and clinical investigations before, during and after therapy with a long- versus a short-half-life benzodiazepine (quazepam versus triazolam).
Saletu B; Anderer P; Brandstätter N; Frey R; Grünberger J; Klösch G; Mandl M; Wetter T; Zeitlhofer J
Neuropsychobiology; 1994; 29(2):69-90. PubMed ID: 8170529
[TBL] [Abstract][Full Text] [Related]
8. Psychotropic drugs in dermatology. A review and guidelines for use.
Gupta MA; Gupta AK; Haberman HF
J Am Acad Dermatol; 1986 Apr; 14(4):633-45. PubMed ID: 2870093
[TBL] [Abstract][Full Text] [Related]
9. Notes on human behavioural pharmacotoxicology.
De Maio D
Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(1):33-40. PubMed ID: 2896371
[TBL] [Abstract][Full Text] [Related]
10. The rational use of psychotropic drugs in pregnancy and postpartum.
Robinson GE; Stewart DE; Flak E
Can J Psychiatry; 1986 Apr; 31(3):183-90. PubMed ID: 2871917
[TBL] [Abstract][Full Text] [Related]
11. Drugs for psychiatric disorders.
Med Lett Drugs Ther; 1980 Sep; 22(19):77-84. PubMed ID: 6106886
[No Abstract] [Full Text] [Related]
12. [The dangers of the sudden discontinuation of drugs].
de Graeff PA
Ned Tijdschr Geneeskd; 1985 Jun; 129(22):1034-9. PubMed ID: 2861575
[No Abstract] [Full Text] [Related]
13. [Problems of psychopharmacological therapy in pregnancy].
Piccione E
Clin Ter; 1988 Mar; 124(6):483-7. PubMed ID: 2904847
[No Abstract] [Full Text] [Related]
14. Psychologists and psychoactive drugs.
Murray JB
Genet Psychol Monogr; 1978 Nov; 98(Second Half):281-323. PubMed ID: 31317
[TBL] [Abstract][Full Text] [Related]
15. Pharmacology in the elderly: psychological and physiological interrelationships.
Hooyman NW; Gambert SR
Psychiatr Med; 1983 Dec; 1(4):445-58. PubMed ID: 6152848
[No Abstract] [Full Text] [Related]
16. Depression Part 3: Medication Related Problems.
Antimisiaris D; McHolan B; Moga D; Mospan C
Sr Care Pharm; 2021 Feb; 36(2):68-82. PubMed ID: 33509330
[TBL] [Abstract][Full Text] [Related]
17. The clinical use of psychotherapeutic drugs in the elderly.
de Groot MH
Drugs; 1974; 8(2):132-8. PubMed ID: 4154836
[No Abstract] [Full Text] [Related]
18. Risk of seizures associated with psychotropic medications: emphasis on new drugs and new findings.
Lee KC; Finley PR; Alldredge BK
Expert Opin Drug Saf; 2003 May; 2(3):233-47. PubMed ID: 12904103
[TBL] [Abstract][Full Text] [Related]
19. Congenital malformations with psychopharmacologic agents.
Ananth J
Compr Psychiatry; 1975; 16(5):437-45. PubMed ID: 240643
[No Abstract] [Full Text] [Related]
20. Drugs for psychiatric disorders.
Med Lett Drugs Ther; 1976 Oct; 18(22):89-96. PubMed ID: 10519
[No Abstract] [Full Text] [Related]
[Next] [New Search]
